178 related articles for article (PubMed ID: 34615424)
1. Implication of RAGE Polymorphic Variants in COPD Complication and Anti-COPD Therapeutic Potential of sRAGE.
Malik P; Hoidal JR; Mukherjee TK
COPD; 2021 Dec; 18(6):737-748. PubMed ID: 34615424
[TBL] [Abstract][Full Text] [Related]
2. The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease.
Sharma A; Kaur S; Sarkar M; Sarin BC; Changotra H
Clin Rev Allergy Immunol; 2021 Apr; 60(2):244-258. PubMed ID: 33170477
[TBL] [Abstract][Full Text] [Related]
3. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
4. Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.
Yonchuk JG; Silverman EK; Bowler RP; Agustí A; Lomas DA; Miller BE; Tal-Singer R; Mayer RJ
Am J Respir Crit Care Med; 2015 Oct; 192(7):785-92. PubMed ID: 26132989
[TBL] [Abstract][Full Text] [Related]
5. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
[TBL] [Abstract][Full Text] [Related]
6. The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
Miller S; Henry AP; Hodge E; Kheirallah AK; Billington CK; Rimington TL; Bhaker SK; Obeidat M; Melén E; Merid SK; Swan C; Gowland C; Nelson CP; Stewart CE; Bolton CE; Kilty I; Malarstig A; Parker SG; Moffatt MF; Wardlaw AJ; Hall IP; Sayers I
PLoS One; 2016; 11(10):e0164041. PubMed ID: 27755550
[TBL] [Abstract][Full Text] [Related]
7. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation.
Romero R; Espinoza J; Hassan S; Gotsch F; Kusanovic JP; Avila C; Erez O; Edwin S; Schmidt AM
J Perinat Med; 2008; 36(5):388-98. PubMed ID: 18593373
[TBL] [Abstract][Full Text] [Related]
8. Soluble receptor for advanced glycation end-products and progression of airway disease.
Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
[TBL] [Abstract][Full Text] [Related]
9. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
[TBL] [Abstract][Full Text] [Related]
10. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
[TBL] [Abstract][Full Text] [Related]
11. Association between plasma sRAGE and emphysema according to the genotypes of AGER gene.
Sin S; Lim MN; Kim J; Bak SH; Kim WJ
BMC Pulm Med; 2022 Feb; 22(1):58. PubMed ID: 35144588
[TBL] [Abstract][Full Text] [Related]
12. Soluble RAGE is deficient in neutrophilic asthma and COPD.
Sukkar MB; Wood LG; Tooze M; Simpson JL; McDonald VM; Gibson PG; Wark PA
Eur Respir J; 2012 Mar; 39(3):721-9. PubMed ID: 21920897
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end products: a new theraputic target for chronic obstructive pulmonary disease?
Chen L; Liu L; Wang T; Shen YC; Wen FQ
Arch Med Res; 2013 Jan; 44(1):75-6. PubMed ID: 23287523
[TBL] [Abstract][Full Text] [Related]
14. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
[TBL] [Abstract][Full Text] [Related]
15. Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury.
Miyagawa T; Iwata Y; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Kamikawa Y; Miyake T; Kitajima S; Toyama T; Hara A; Sakai N; Shimizu M; Furuichi K; Munesue S; Yamamoto Y; Kaneko S; Wada T
Biol Open; 2022 Jan; 11(1):. PubMed ID: 34812852
[TBL] [Abstract][Full Text] [Related]
16. The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients.
Kinjo T; Kitaguchi Y; Droma Y; Yasuo M; Wada Y; Ueno F; Ota M; Hanaoka M
Sci Rep; 2020 Jul; 10(1):12811. PubMed ID: 32732977
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
18. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
Yamagishi S; Matsui T; Nakamura K
Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
[TBL] [Abstract][Full Text] [Related]
19. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
Scavello F; Tedesco CC; Castiglione S; Maciag A; Sangalli E; Veglia F; Spinetti G; Puca AA; Raucci A
Biomark Med; 2021 Aug; 15(11):785-796. PubMed ID: 34236256
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation endproducts and their receptor in different body compartments in COPD.
Hoonhorst SJ; Lo Tam Loi AT; Pouwels SD; Faiz A; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; van Oosterhout AJ; Lodewijk ME; Timens W; Postma DS; Ten Hacken NH
Respir Res; 2016 Apr; 17():46. PubMed ID: 27117828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
